These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16184412)

  • 1. Direct autoradiographic evidence that rebamipide interacts with neutrophils in dextran sulfate sodium induced colitis in rats.
    Nakamura M; Takahashi T; Matsumoto T; Atsuda K; Hibi N; Matsui H; Yamada H; Tsuchimoto K
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S113-8. PubMed ID: 16184412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis.
    Okayama M; Tsubouchi R; Nishio H; Kato S; Takeuchi K
    Digestion; 2004; 70(4):240-9. PubMed ID: 15687726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.
    Nakashima T; Maeda T; Nagamoto H; Kumakura T; Takai M; Mori T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S124-31. PubMed ID: 16184415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.
    Kishimoto S; Haruma K; Tari A; Sakurai K; Nakano M; Nakagawa Y
    Dig Dis Sci; 2000 Aug; 45(8):1608-16. PubMed ID: 11007113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice.
    Jang H; Park S; Lee J; Myung JK; Jang WS; Lee SJ; Myung H; Lee C; Kim H; Lee SS; Jin YW; Shim S
    J Gastroenterol Hepatol; 2018 Apr; 33(4):878-886. PubMed ID: 29047150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by rebamipide against acetic acid-induced colitis in rats: relationship with its antioxidative activity.
    Sakurai K; Osaka T; Yamasaki K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):125S-133S. PubMed ID: 9753238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide.
    Iwai A; Iwashita E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):143S-147S. PubMed ID: 9753241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites.
    Nakamura M; Asada M; Matsui H; Hibi N; Tsuchimoto K; Inoue J; Oda M
    Clin Hemorheol Microcirc; 2006; 34(1-2):193-9. PubMed ID: 16543636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis.
    Nakamura M; Asada M; Atsuda K; Matsui H; Watanabe T; Higuchi K; Arakawa T; Hibi N; Tsuchimoto K
    Inflammopharmacology; 2005; 13(1-3):303-15. PubMed ID: 16259749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
    Sakurai K; Osaka T; Yamasaki K
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide.
    Zea-Iriarte WL; Makiyama K; Goto S; Murase K; Urata Y; Sekine I; Hara K; Kondo T
    Scand J Gastroenterol; 1996 Oct; 31(10):985-92. PubMed ID: 8898419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: rebamipide and the digestive epithelial barrier.
    Matysiak-Budnik T; Heyman M; Mégraud F
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():55-62. PubMed ID: 12925141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rectal administration of rebamipide on dextran sulfate sodium-induced colitis: role of hepatocyte growth factor.
    Murai R; Kanbe T; Mukoyama T; Shimomura T; Hashiguchi K; Yoshida Y; Tsuchiya H; Hoshikawa Y; Kurimasa A; Shiota G
    Inflamm Res; 2007 Jun; 56(6):240-5. PubMed ID: 17607548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
    Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
    World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide binds to iNOS-positive cells in acetic acid-treated but not in ethanol-treated rat gastric mucosa.
    Nakamura M; Akiba Y; Matsui H; Tsuchimoto K; Ishii H
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():76-81. PubMed ID: 12925143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats.
    Nakashima T; Uematsu N; Sakurai K
    Support Care Cancer; 2017 Jul; 25(7):2205-2213. PubMed ID: 28204991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVALUATION OF THE EFFECT OF REBAMIPIDE ON THE PROGRESSION OF ULCERATIVE COLITIS IN RATS IN THE EXPERIMENT.
    Bikbaeva K; Kovalenko E; Vedeleva K; Pichkurova G; Maranyan M; Baybuz B; Baymurzaev I; Cenenko E; Kurmagomadov A; Ataev A; Malsagov S
    Georgian Med News; 2024 Mar; (348):151-153. PubMed ID: 38807409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution.
    Takagi T; Naito Y; Uchiyama K; Okuda T; Mizushima K; Suzuki T; Handa O; Ishikawa T; Yagi N; Kokura S; Ichikawa H; Yoshikawa T
    World J Gastroenterol; 2011 Sep; 17(33):3802-9. PubMed ID: 21987622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoemulsions of Rebamipide: Formulation, Characterization, and In Vivo Evaluation of Pharmacokinetic and Pharmacodynamic Effects.
    Narala A; Guda S; Veerabrahma K
    AAPS PharmSciTech; 2019 Jan; 20(1):26. PubMed ID: 30604333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.